Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024 ...

Tempus AI, Inc.’s TEM investors have been encountering short-term losses from the stock of late.Shares of the Chicago, IL-based healthcare technology company focused on adopting artificial ...

Tempus AI was one of them. Pelosi purchased 50 call options with a strike price of $20 that also expire on Jan. 16, 2026. The value of the trade was between $50,000 and $100,000.

Shares of Tempus AI Inc. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7.5 billion. The rally was driven by headline-grabbing news and strong market sentiment ...

Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...

Tempus Ai got a big valuation boost following a disclosure that Nancy Pelosi had purchased call options for the stock. The healthcare AI company also unveiled its new software service today. In a ...

Tempus AI recently completed the acquisition of Ambry Genetics. The transaction enables it to expand into other areas of healthcare. Management projects strong year-over-year revenue growth for ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing. The ...

Former House Speaker Nancy Pelosi discloses the purchase of 50 call options in Tempus AI with a strike price of $20. Tempus AI on Tuesday announced the national launch of its AI-enabled personal ...

CHICAGO, February 13, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new ...

In addition to the financial information presented in this release in accordance with accounting principles generally accepted in the United States of America (GAAP), Tempus also presents the non ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the 43rd Annual J.P ...